Related Experiment Video
Updated: Jan 13, 2026

Conducting Respiratory Oscillometry in an Outpatient Setting
Published on: April 8, 2022
COMPAIR: a comparison of directly supervised clinic versus virtually supervised home spirometry
Ashish Pradhan1, Jacqui Pollington2, Dinesh Saralaya3
1The Nottingham Asthma Centre, Nottingham City Hospital NHS Foundation Trust, Nottingham, UK.
Background:
Our objectives were to compare directly supervised in clinic spirometry (DSCS) with virtually supervised at home spirometry (VSHS), assess the utility of artificial intelligence (AI) over-reading and evaluate patients' views of VSHS.
Methods:
A multicentre, prospective, 8-day study was conducted in adult patients with physician-diagnosed asthma or COPD from UK primary/secondary care. Spirometry (forced expiratory volume in 1 s (FEV1) and forced vital capacity (FVC)) was performed using the NuvoAir Air Next Bluetooth portable spirometer supported by trained healthcare providers (HCPs) in clinic (Days 1 and 8) and virtually supervised at home (Days 2 and 7). Over-reading was done manually and by ArtiQ.QC (cloud-based AI). Inter-method concordance and agreement were assessed by correlation analyses and Bland-Altman plots, respectively. Participants completed a questionnaire (Day 8) to assess their views on VSHS.
Results:
68 participants were included (asthma: n=47; COPD: n=21). There was excellent concordance between HCP-over-read DSCS (Day 1) and VSHS (Day 2) as indicated by intraclass correlation coefficients for FEV1 (0.95 (95% CI 0.92-0.97)) and FVC (0.95 (95% CI 0.92-0.97)), which were slightly higher when over-read by ArtiQ.QC (FEV1: 0.98 (95% CI 0.97-0.99); FVC: 0.96 (95% CI 0.93-0.97)). Bland-Altman plots showed good agreement between DSCS and VSHS, for both manual and ArtiQ.QC over-read assessments, with evidence of better agreement when over-read by ArtiQ.QC. More than 95% of patients considered the NuvoAir spirometer and mobile app easy to use and would be happy to use it in the future.
Conclusions:
VSHS with the NuvoAir spirometer and ArtiQ.QC over-reading offers reliable and consistent measures of lung function for research purposes and potential clinical application in a population of patients with asthma or COPD. VSHS coupled with AI over-read allows spirometry to be performed at a more convenient location for patients while maintaining high-quality results, comparable to clinic-based spirometry.
Related Concept Videos
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Pulmonary Function Tests
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
COPD: Management Using Bronchodilators and Corticosteroids
Assessment of Ventilation II: Respiratory Depth and Rhythm
Respiratory depth measures the volume of air inhaled or exhaled during a breath. It can vary from shallow to deep and typically remains consistent when a person is at rest or asleep. Occasionally, individuals will automatically inhale deeply, known as sighing, which inflates the lungs with more air than normal breathing.
To assess respiratory depth, observe the degree of chest excursion or movement:
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Assessment of Ventilation I: Respiratory Rate
A Ventilation assessment is critical for monitoring a patient's health status. Respiration, one of the most accessible vital signs, provides insights into the function of numerous body systems and can indicate serious health issues, such as brainstem injuries from head trauma.
Critical Guidelines for Assessing Ventilation:

